What is James Alexander?
Founded in 1976, James Alexander Corporation has established itself as a critical player in the development and production of innovative single-use packaging systems. The company specializes in high-precision solutions, including glass and plastic ampoules, snap-top vials, unit dose swabs, and dropper tip assemblies. Operating at the intersection of medical device manufacturing and pharmaceutical packaging, the firm maintains rigorous quality assurance standards to meet stringent FDA requirements. Their portfolio, which includes essential medical products like amyl nitrite and povidone iodine solutions, serves a diverse client base that relies on the company's expertise in unit-dose delivery mechanisms and reliable contract filling services.
How much funding has James Alexander raised?
James Alexander has raised a total of $20K across 1 funding round:
Debt
$20K
Debt (2021): $20K with participation from PPP
Key Investors in James Alexander
PPP
Public-Private Partnership
What's next for James Alexander?
With the infusion of this recent capital, James Alexander Corporation is expected to prioritize the modernization of its production facilities and the expansion of its proprietary packaging technologies. As the demand for sterile, single-use medical delivery systems continues to rise, the company is strategically positioned to capture additional market share. Future growth initiatives will likely focus on operational efficiency, supply chain resilience, and the potential development of new, specialized delivery formats that address evolving clinical needs. By maintaining its long-standing commitment to quality and customer-centric service, the firm is poised to solidify its reputation as a leader in the contract packaging industry.
See full James Alexander company page
